News Standigm Raises US $11.5 Million in Series B Round Funding to advance its AI-powered drug pipelines toward license-out

March 27, 2019

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has raised 11.5 million dolloar in a Series B funding round led by Mirae Asset Venture Investment and Mirae Asset Capital. Standigm will use the funds to scale the AI technology platforms and advance its drug discovery pipelines toward license-out. The new round brings Standigm’s total financing to $15 million.

Event BIO International Convention 2018

April 12, 2018

Date : June 4-7, 2018
Location : Boston, MA, USA
Jinhan Kim, Standigm CEO, and Heejung Koo will attend the BIO International Convention 2018.

Event BIO Asia International Conference 2018

February 22, 2018

Date : March 19-20, 2018
Location : Tokyo, Japan
Jinhan Kim, Standigm CEO, and Daehee Han will attend the BIO Asia International Conference 2018.